InspireMD to Present at Harvard Investors Group on June 27 in New York
TEL AVIV, Israel, June 25, 2012 /PRNewswire/ --
InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, today announced that management will present at the Harvard Investors Group meeting in New York on Wednesday, June 27.
Date: Wednesday, June 27, 2012
Time: 5.15 pm at dinner (cocktails 4.30 - 5.15 pm)
Location: The Manhattan Club, New York NY.
Presenting on behalf of InspireMD will be Craig Shore, CFO.
About InspireMD, Inc.
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is listed on the OTC BB under the ticker symbol "NSPR".
About the Harvard Investors Group
The Harvard Investors Group is an active group of qualified investors and investment professionals - including senior analysts, fund managers, and investment advisors - within the New York City financial and investment industries.
Attendance at all Harvard Investors Group meetings is limited to invited guests only.
This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, a